Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity (2016 - 2025)

Historic Common Equity for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $7.2 million.

  • cbdMD's Common Equity rose 26803.73% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 26803.73%. This contributed to the annual value of $7.2 million for FY2025, which is 26803.73% up from last year.
  • cbdMD's Common Equity amounted to $7.2 million in Q3 2025, which was up 26803.73% from $6.1 million recorded in Q2 2025.
  • cbdMD's 5-year Common Equity high stood at $103.1 million for Q3 2021, and its period low was $665798.0 during Q1 2025.
  • For the 5-year period, cbdMD's Common Equity averaged around $33.6 million, with its median value being $25.7 million (2023).
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 8823.2% in 2024, then surged by 26803.73% in 2025.
  • Quarter analysis of 5 years shows cbdMD's Common Equity stood at $84.4 million in 2021, then plummeted by 68.49% to $26.6 million in 2022, then plummeted by 73.54% to $7.0 million in 2023, then plummeted by 74.68% to $1.8 million in 2024, then surged by 305.6% to $7.2 million in 2025.
  • Its Common Equity was $7.2 million in Q3 2025, compared to $6.1 million in Q2 2025 and $665798.0 in Q1 2025.